List of Excipients in API hydrocortisone and acetic acid
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrocortisone and acetic acid
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Akorn Operating Company LLC | HYDROCORTISONE AND ACETIC ACID | hydrocortisone and acetic acid | 50383-901 | ANHYDROUS CITRIC ACID | |
| Akorn Operating Company LLC | HYDROCORTISONE AND ACETIC ACID | hydrocortisone and acetic acid | 50383-901 | BENZETHONIUM CHLORIDE | |
| Akorn Operating Company LLC | HYDROCORTISONE AND ACETIC ACID | hydrocortisone and acetic acid | 50383-901 | PROPYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydrocortisone and acetic acid
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 | ANHYDROUS CITRIC ACID |
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 | BENZETHONIUM CHLORIDE |
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 | PROPYLENE GLYCOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydrocortisone and acetic acid
Excipient focus: ANHYDROUS CITRIC ACID
hydrocortisone and acetic acid drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 |
| Akorn Operating Company LLC | hydrocortisone and acetic acid | 50383-901 |
| Taro Pharmaceuticals USA Inc | hydrocortisone and acetic acid | 51672-3007 |
| >Company | >Ingredient | >NDC |
hydrocortisone and acetic acid drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BENZETHONIUM CHLORIDE
hydrocortisone and acetic acid drug variants containing BENZETHONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 |
| Akorn Operating Company LLC | hydrocortisone and acetic acid | 50383-901 |
| Taro Pharmaceuticals USA Inc | hydrocortisone and acetic acid | 51672-3007 |
| >Company | >Ingredient | >NDC |
hydrocortisone and acetic acid drug variants not containing BENZETHONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrocortisone and acetic acid drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 |
| Akorn Operating Company LLC | hydrocortisone and acetic acid | 50383-901 |
| Taro Pharmaceuticals USA Inc | hydrocortisone and acetic acid | 51672-3007 |
| >Company | >Ingredient | >NDC |
hydrocortisone and acetic acid drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL DIACETATE
hydrocortisone and acetic acid drug variants containing PROPYLENE GLYCOL DIACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 |
| Akorn Operating Company LLC | hydrocortisone and acetic acid | 50383-901 |
| Taro Pharmaceuticals USA Inc | hydrocortisone and acetic acid | 51672-3007 |
| >Company | >Ingredient | >NDC |
hydrocortisone and acetic acid drug variants not containing PROPYLENE GLYCOL DIACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
hydrocortisone and acetic acid drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone and acetic acid | 0713-0849 |
| Akorn Operating Company LLC | hydrocortisone and acetic acid | 50383-901 |
| Taro Pharmaceuticals USA Inc | hydrocortisone and acetic acid | 51672-3007 |
| >Company | >Ingredient | >NDC |
hydrocortisone and acetic acid drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch